Злой рок. Политика катастроф

Фергюсон Ниал

Вернуться

1081

Liu Tao et al., «Prevalence of IgG Antibodies to SARS-CoV2 in Wuhan – Implications for the Ability to Produce Long-Lasting Protective Antibodies Against SARS-CoV2», MedRxiv, June 16, 2020, pp. 1-30, https://doi.org/10.1101/2020.06.13.20130252; Henry M. Staines et al., «Dynamics of IgG Seroconversion and Pathophysiology of COVID-19 Infections», MedRxiv, June 9, 2020), pp. 1-21, https://doi.org/10.1101/2020.06.07.20124636; Long Quan-Xin et al., «Clinical and Immunological Assessment of Asymptomatic SARS-CoV2 Infections», Nature Medicine 26 (June 18, 2020), pp. 1200–1204, https://doi.org/10.1038/s41591-020-09656; F. Javier Ibarrondo et al., «Rapid Decay of Anti-SARS-CoV2 Antibodies in Persons with Mild COVID-19», NEJM, July 21, 2020, pp. 1–2, https://doi.org/10.1056/NEJMc2025179.

Вернуться

1082

Bao Linlin et al.,

«Reinfection Could Not Occur in SARS-CoV2 Infected Rhesus Macaques», BioRxiv, March 14, 2020, pp. 1-20, https://doi.org/10.1101/2020.03.13.990226; Deng Wei et al., «Primary Exposure to SARS-CoV2 Protects Against Reinfection in Rhesus Macaques», Science 369, no. 6505 (August 14, 2020), pp. 818–823, https://doi.org/10.1126/science.abc5343; «News Room: Press Release», Korean Centers for Disease Control, https://www.cdc.go.kr/board/board.es?mid=a30402000000 &bid=0030; Roman Woelfel et al., «Clinical Presentation and Virological Assessment of Hospitalized Cases of Coronavirus Disease 2019 in a Travel-Associated Transmission Cluster», MedRxiv, March 8, 2020, pp. 1-16, https://doi.org/10.1101/2020.03.05.20030502; Ania Wajnberg et al., «Humoral Immune Response and Prolonged PCR Sensitivity in a Cohort of 1343 SARS-CoV2 Patients in the New York City Region», MedRxiv, May 5, 2020, pp. 1-17, https://doi.org/10.1101/2020.04.30.20085613. Однако см.: Apoorva Mandavilli, «First Documented Coronavirus Reinfection Reported in Hong Kong», New York Times, August 24, 2020, https://www.nytimes.com/2020/08/24/health/coronavirus-reinfection.html.

Вернуться

1083

Paul K. Hegarty et al., «BCG Vaccination May Be Protective Against COVID-19», March 2020, pp. 1–8, Research Gate, https://doi.org/10.13140/RG.2.2.35948.10880; Martha K. Berg et al., «Mandated Bacillus Calmette-Guerin (BCG) Vaccination Predicts Flattened Curves for the Spread of COVID-19», MedRxiv, June 12, 2020, pp. 1-15, https://doi.org/10.1101/2020.04.05.20054163; Akiko Iwasaki and Nathan D. Grubaugh, «Why Does Japan Have So Few Cases of COVID-19?» European Molecular Biology Organization (EMBO) Molecular Medicine 12, no. 5 (May 8, 2020), pp. 1–3, https://doi.org/10.15252/emmm.202012481; Luis E. Escobar, Alvaro Molina-Cruz, and Carolina Barillas-Mury, «BCG Vaccine Protection from Severe Coronavirus Disease 2019 (COVID-19)», PNAS, June 9, 2020, pp. 1–7, https://doi.org/10.1073/pnas.2008410117.

Вернуться

1084

Zhao Jiao et al., «Relationship Between the ABO Blood Group and the COVID-19 Susceptibility», MedRxiv, March 27, 2020, pp. 1-18, https://doi.org/10.1101/2020.03.11.20031096; David Ellinghaus et al., «Genomewide Association Study of Severe COVID-19 with Respiratory Failure», NEJM, June 17, 2020, pp. 1-13, https://doi.org/10.1056/NEJMoa2020283; Gabi Zietsman, «One Blood Type Seems to Be More Resistant Against COVID-19», Health24 Infectious Diseases, June 15, 2020, https://www.health24.com/Medical/Infectious-diseases/Coronavirus/one-blood-type-seemstobemore-resistant-against-covid19202006132.

Вернуться

1085

Takuya Sekine et al., «Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19», BioRxiv, June 29, 2020, pp. 1-35, https://doi.org/10.1101/2020.06.29.174888; Li Junwei et al., «Mapping the T Cell Response to COVID-19», Nature Signal Transduction and Targeted Therapy 5, no. 112 (July 2, 2020), pp. 1–2, https://doi.org/10.1038/s41392-020-002281; Alessandro Sette and Shane Crotty, «Pre-Existing Immunity to SARS-CoV2: The Knowns and Unknowns», Nature Reviews Immunology 20 (July 7, 2020), pp. 457–458, https://doi.org/10.1038/s41577-020-0389z; Floriane Gallaise et al., «Intrafamilial Exposure to SARS-CoV2 Induces Cellular Immune Response Without Seroconversion», MedRxiv, June 22, 2020, pp. 1-15, https://doi.org/10.1101/2020.06.21.20132449; Paul W. Franks and Joacim Rocklov,

«Coronavirus: Could It Be Burning Out After 20 % of a Population Is Infected?» The Conversation, June 29, 2020, https://theconversation.com/coronavirus-coulditbeburning-out-after20ofapopulationisinfected-141584; Julian Braun et al., «Presence of SARS-CoV2 Reactive T Cells in COVID-19 Patients and Healthy Donors», MedRxiv, April 22, 2020, pp. 1-12, https://doi.org/10.1101/2020.04.17.20061440; Kevin W. Ng et al., «Pre-Existing and De Novo Humoral Immunity to SARS-CoV2 in Humans», BioRxiv, July 23, 2020, pp. 1-38, https://doi.org/10.1101/2020.05.14.095414; Nikolai Eroshenko et al., «Implications of Antibody-Dependent Enhancement of Infection for SARS-CoV2 Countermeasures», Nature Biotechnology 38 (June 5, 2020), pp. 789–791, https://doi.org/10.1038/s41587-020-05771.

Вернуться

1086

UnHerd, «Karl Friston: Up to 80 % Not Even Susceptible to COVID-19», June 4, 2020, YouTube video, 34:14, https://youtu.be/dUOFeVIrOPg; Laura Spinney, «COVID-19 Expert Karl Friston: ‘Germany May Have More Immunological Dark Matter,’» Guardian, May 31, 2020, https://www.theguardian.com/world/2020/may/31/covid19expert-karl-friston-germany-may-have-more-immunological-dark-matter.

Вернуться

1087

Jia Yong et al., «Analysis of the Mutation Dynamics of SARS-CoV2 Reveals the Spread History and Emergence of RBD Mutant with Lower ACE2 Binding Affinity», BioRxiv, April 11, 2020, pp. 1-17, https://doi.org/10.1101/2020.04.09.034942; B. Korber et al., «Spike Mutation Pipeline Reveals the Emergence of a More Transmissible Form of SARS-CoV2», BioRxiv, April 30, 2020, pp. 1-33, https://doi.org/10.1101/2020.04.29.069054. См. также: Stephen Chen, «Coronavirus’s Ability to Mutate Has Been Vastly Underestimated, and Mutations Affect Deadliness of Strains, Chinese Study Finds», South China Morning Post, April 20, 2020, https://www.scmp.com/news/china/science/article/3080771/coronavirus-mutations-affect-deadliness-strains-chinese-study.

Вернуться

1088

Joshua Geleris et al., «Observational Study of Hydroxychloroquine in Hospitalized Patients with COVID-19», NEJM, June 18, 2020, https://www.nejm.org/doi/full/10.1056/nejmoa2012410; Alexandre B. Cavalcanti et al., «Hydroxychloroquine With or Without Azithromycin in Mild-to-Moderate COVID-19», NEJM, July 23, 2020, https://www.nejm.org/doi/full/10.1056/NEJMoa2019014; David R. Boulware et al.,

«A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for COVID-19», NEJM, July 23, 2020, https://www.nejm.org/doi/full/10.1056/NEJMoa2016638.

Вернуться

1089

«COVID-19 Vaccine Tracker», Faster Cures, Milken Institute, August 14, 2020, https://www.covid-19vaccinetracker.org/. См. в целом: Tung Thanh Le et al., «The COVID-19 Vaccine Development Landscape», Nature Reviews Drug Discovery 19 (April 9, 2020), pp. 305–306, https://doi.org/10.1038/d41573-020-000735.

Вернуться

1090

Stuart A. Thompson, «How Long Will a Vaccine Really Take?» New York Times, April 30, 2020, https://www.nytimes.com/interactive/2020/04/30/opinion/coronavirus-covid-vaccine.html.

Вернуться

1091

Nicholas Kumleben, R. Bhopal, T. Czypionka, L. Gruer, R. Kock, Justin Stebbing, and F. L. Stigler, «Test, Test, Test for COVID-19 Antibodies: The Importance of Sensitivity, Specificity and Predictive Powers», Public Health 185 (August 2020), pp. 88–90, https://doi.org/10.1016/j.puhe.2020.06.006.